Invesco Pharmaceuticals ETF
PJP
69 hedge funds and large institutions have $181M invested in Invesco Pharmaceuticals ETF in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 20
18% more capital invested
Capital invested by funds: $154M → $181M (+$27.1M)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
1% less funds holding
Funds holding: 70 → 69 (-1)
2.25% less ownership
Funds ownership: 28.66% → 26.42% (-2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$9.36M |
| 2 |
Morgan Stanley
New York
|
+$7.68M |
| 3 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
+$4.16M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.78M |
| 2 |
Rafferty Asset Management
New York
|
-$4.35M |
| 3 |
SG Americas Securities
New York
|
-$2.85M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.49M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$1.3M |
PJP Hedge Fund Activity: Q3 2013 in Review
69 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2013, worth a combined $181M — up 18% from $154M a quarter earlier.
Fund positioning in PJP was balanced in Q3 2013: 9 funds opened new positions, 9 closed out, 31 added to existing stakes and 20 trimmed.
The largest buyer was LPL Financial, adding an estimated $9.36M. The largest seller was Fidelity Investments, exiting entirely with an estimated $9.78M sold.
- 69 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2013, down from 70 in Q2 2013.
- Funds reported $181M of Invesco Pharmaceuticals ETF stock for Q3 2013, up 18% quarter-over-quarter.
- 9 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2013 and 9 closed out, a net change of 0 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2013 was LPL Financial, an estimated $9.36M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2013 was Fidelity Investments, an estimated $9.78M sold.
Based on aggregated 13F filings for Q3 2013.